产品标题 产品货号 产品规格 厂家
Human RNA: Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIESCR5595395 ugORIGENE TECHNOLOGIES
Human RNA: Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIESCR5595575 ugORIGENE TECHNOLOGIES
Human RNA: Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIESCR5602475 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 21 (CXorf21) from ORIGENE TECHNOLOGIESLY403054100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 23 (CXorf23) from ORIGENE TECHNOLOGIESLY405004100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 26 (CXorf26) from ORIGENE TECHNOLOGIESLY413940100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 27 (CXorf27) from ORIGENE TECHNOLOGIESLY415843100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 38 (CXorf38) from ORIGENE TECHNOLOGIESLY408112100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 49 (CXorf49) from ORIGENE TECHNOLOGIESLY428719100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 51 (CXorf51) from ORIGENE TECHNOLOGIESLY428491100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 59 (CXorf59) from ORIGENE TECHNOLOGIESLY406565100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 61 (CXorf61) from ORIGENE TECHNOLOGIESLY400409100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 64 (CXorf64) from ORIGENE TECHNOLOGIESLY426551100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 66 (CXorf66) from ORIGENE TECHNOLOGIESLY422968100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 36 (CXorf36), transcript variant 1 from ORIGENE TECHNOLOGIESLY430455100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 41 (CXorf41), transcript variant 1 from ORIGENE TECHNOLOGIESLY432700100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 41 (CXorf41), transcript variant 2 from ORIGENE TECHNOLOGIESLY406577100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 48 (CXorf48), transcript variant 1 from ORIGENE TECHNOLOGIESLY422158100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 48 (CXorf48), transcript variant 2 from ORIGENE TECHNOLOGIESLY413485100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 56 (CXorf56), transcript variant 1 from ORIGENE TECHNOLOGIESLY411776100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 56 (CXorf56), transcript variant 2 from ORIGENE TECHNOLOGIESLY432632100 ugORIGENE TECHNOLOGIES
Chromosome X open reading frame 65 (CXorf65), transcript variant 1 from ORIGENE TECHNOLOGIESLY422501100 ugORIGENE TECHNOLOGIES
Chromosome Y open reading frame 15A (CYorf15A) from ORIGENE TECHNOLOGIESLY423662100 ugORIGENE TECHNOLOGIES
Chromosome Y open reading frame 15B (CYorf15B) from ORIGENE TECHNOLOGIESLY410032100 ugORIGENE TECHNOLOGIES
Chronic lymphocytic leukemia up-regulated 1 opposite strand (CLLU1OS) from ORIGENE TECHNOLOGIESLY422486100 ugORIGENE TECHNOLOGIES
CHST12 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4025141 kitORIGENE TECHNOLOGIES
CHST11 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4030371 kitORIGENE TECHNOLOGIES
CHST10 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4037931 kitORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCS7021925x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCS7057095x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCS7057105x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCS7057115x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCS8003645x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIESCS8008785x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, metastatic from ORIGENE TECHNOLOGIESCS7052485x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, metastatic from ORIGENE TECHNOLOGIESCS7052495x5umORIGENE TECHNOLOGIES
Human Cervix; Carcinoma of cervix, squamous cell, metastatic from ORIGENE TECHNOLOGIESCS5177035x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis from ORIGENE TECHNOLOGIESCS7013215x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis from ORIGENE TECHNOLOGIESCS7105145x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis from ORIGENE TECHNOLOGIESCS7119865x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis from ORIGENE TECHNOLOGIESCS8099395x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis from ORIGENE TECHNOLOGIESCS5306775x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis from ORIGENE TECHNOLOGIESCS6357565x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis, acute from ORIGENE TECHNOLOGIESCS8017845x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis, chronic from ORIGENE TECHNOLOGIESCS7057475x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis, chronic from ORIGENE TECHNOLOGIESCS7095655x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis, chronic from ORIGENE TECHNOLOGIESCS7095765x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis, chronic from ORIGENE TECHNOLOGIESCS8095345x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis, chronic from ORIGENE TECHNOLOGIESCS8095585x5umORIGENE TECHNOLOGIES
Human Cervix; Cervicitis, chronic from ORIGENE TECHNOLOGIESCS8095965x5umORIGENE TECHNOLOGIES
 |< < 3223 3224 3225 3226 3227 3228 3229 3230 3231 > >| 第 3230/6274 页